维普中文期刊产品整合服务
27篇 您的检索式:作者名="Xiol"
    题名 作者 年代 出处 被引量
1Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis显示文摘Xavier Ariza José Castellote Jaime Lora-Tamayo Anna Girbau Sílvia Salord Rosa Rota Javier Ariza Xavier Xiol 2011Journal of Hepatology2011,,4:5
2Serious drug-induced liver disease secondary to ezetimibe显示文摘Ezetimibe is the f irst member of a new family of lipid- lowering drugs that inhibits uptake of dietary and bili- ary cholesterol. It was approved by the FDA in 2002 for hypercholesterolemia alone or in combination with statins. Its use has been spreading over the last years. Ezetimibe was considered a safe drug. We report a case of a woman who developed a serious hepatocellular drug-induced liver disease after 4 mo therapy with 10 mg daily of ezetimibe. After withdrawal of the drug, the patient recovered slowly. Ezetimibe may produce seri- ous toxic hepatitis and prompt withdrawal is mandatory in case of a signif icant abnormality in liver testing after beginning or during treatment with ezetimibe.José Castellote Javier Ariza Rosa Rota Anna Girbau Xavier Xiol 2008World Journal of Gastroenterology2008,14,32:3
3Clinically relevant differ ences in the model for end-stage liver disease and model for end-stage liver diseaae-sodium scores determined at three uni- versity-based laboratories of the same area显示文摘Xiol X Gines P Caste-Us L 2009Liver Transpl2009,15,3:1
4Usefulness and complications of thoracentesis in cirrhotic patients显示文摘Xavier Xiol Jose Castellote Ricart Cortes-Beut Mercedes Delgado Jordi Guardiola Eva Sesé 2001The American Journal of Medicine2001,,1:1
5External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites显示文摘Guardiola J Baliellas C Xiol X 2002Am J Gastroenterot2002,97,9:1
6Mouse MOV10L1 associates with Piwi proteins and is an essential component of the Piwi-interacting RNA (piRNA) pathway显示文摘Zheng K Xiol J Reuter M 2010Proc Natl Acad Sci U S A2010,107,11:1
7Immunosuppression without steroids in liver transplantation is safe and reduc- es infection and metabolic complications: results from a prospective multicenter randomized study显示文摘Llado L Xiol X Figueras J 2006J Hepatol2006,44,4:1
8External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites显示文摘Guardiola J Baliellas C Xiol X 2002Am J Gastroenterol2002,97,9:1
9Risk factors for development of de novo neoplasia after liver transplantation显示文摘Xiol X Guardiola J Menendez S 2001Liver Transpl2001,7,11:1
10Spontaneous bacterial empyema in cirrhotic patients:a prospective study显示文摘 Castellvi JM Guardiola J 1996Hepatology1996,23,:1
11Spontaneous bacterial empyema in cirrhotic patients: A prospective study显示文摘X Xiol JM Castellvi J Guardiola E Sese J Castellote A Perello X Cervantes MJ Iborra 1996Hepatology1996,,4:1
12The value of ADA in peritoneal tuberculosis显示文摘Giménez Roca A Xiol X 1992Rev Esp Enferm Dig1992,82,1:1
13Marrow aplasia during high dose mebendazole treatment显示文摘Femandez-Banares F Gonzalez-Huix F Xiol X 1986Am J Trop Med Hyg1986,35,2:1
14Spontaneous bacterial empyema in cirrhotic patients:a prospective study显示文摘Xiol X Castenvi JM Guardiola J 1996Hepatology1996,23,:1
15Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area显示文摘Xiol X Gines P Castells L Liver Transplantation0,,:1
16Low complement levels and opsonic activity in hepatic hydrothorax : its relationship with spontaneous bacterial empyema 显示文摘Sese E Xiol X Castellote J 2003J Clin Gastroenterol2003,36,1:1
17Vitamin status in patients with inflammatory bowel disease 显示文摘Femandez-Banares F Abad-Lacruz A Xiol X 1989The American Journal of Gastroenterology1989,84,7:1
18Risk factors for development of de novo neoplasia after liver transplantation 显示文摘Xiol X Guardiola J Men? endez S 2001Liver Transpl2001,7,:1
19Spontaneous bacterial empyema in cirrhotic patients: a prospective study显示文摘Xiol X Castellvl JM Guardiola J Sese E Castellote J Perell6 A 1996Hepatology1996,23,4:1
20Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multieenter randomized study显示文摘Llado L Xiol X Figueras J 2006J Hepatol2006,44,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费